DistantNews
Manulife Malaysia Revolutionizes Critical Illness Protection with MultiCI Enrich
🇲🇾 Malaysia /Economy & Trade

Manulife Malaysia Revolutionizes Critical Illness Protection with MultiCI Enrich

From Utusan Malaysia · (10m ago) Malay

Translated from Malay, summarized and contextualized by DistantNews.

TLDR

  • Manulife Malaysia launched Manulife MultiCI Enrich (MME), a tiered critical illness solution designed to support Malaysians from early detection through long-term recovery.
  • The new product addresses the reality that critical illnesses can be recurring and evolving, offering multi-phase protection with claims up to age 99 and integrating preventative health tools.
  • MME aims to bridge the financial uncertainty faced by Malaysians who are living longer but dealing with chronic, recurring diseases, by providing multi-tiered coverage for up to 188 health conditions.

Manulife Malaysia is revolutionizing critical illness protection with the launch of Manulife MultiCI Enrich (MME). This innovative, tiered solution is specifically designed to support Malaysians through every stage of their health journey, from the initial diagnosis of a critical illness to long-term recovery.

Our research, the Manulife Asia Care Survey (ACS) 2025, revealed a significant shift in how Malaysians are aging. While people are living longer, this extended lifespan is often accompanied by financial uncertainty due to the recurring nature of chronic diseases. MME directly addresses this evolving reality.

"The experience of facing a critical illness is no longer a single event, but a journey that can last for many years," stated Vibha Coburn, CEO of Manulife Malaysia. "Through Manulife MultiCI Enrich, we are addressing the reality of critical illnesses that can recur and evolve over time. By combining multi-phase claim protection with innovations like pharmacogenomic insights and early cancer detection, we are committed to being with Malaysians every step of their health journey."

MME offers comprehensive, multi-phase protection, covering up to 188 health conditions and allowing for recurring claims up to age 99. It also integrates pharmacogenomic (PGx) support tools to help customers understand their genetic response to medications and provides reimbursement for Multi-Cancer Early Detection (MCED) tests. This holistic approach ensures continuous protection well into old age, a critical need for Malaysians who are living longer but facing increasing health challenges.

The experience of facing a critical illness is no longer a single event, but a journey that can last for many years. Through Manulife MultiCI Enrich, we are addressing the reality of critical illnesses that can recur and evolve over time. By combining multi-phase claim protection with innovations like pharmacogenomic insights and early cancer detection, we are committed to being with Malaysians every step of their health journey.

— Vibha CoburnCEO of Manulife Malaysia, speaking at the launch event about the new product's features and rationale.
DistantNews Editorial

Originally published by Utusan Malaysia in Malay. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.

More Stories

From Our Blog